Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cue Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CUE
Nasdaq
8731
https://www.cuebiopharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cue Biopharma Inc
Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks
- Apr 25th, 2024 1:35 pm
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apr 24th, 2024 2:01 pm
Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now
- Apr 15th, 2024 1:55 pm
Q4 2023 Cue Biopharma Inc Earnings Call
- Apr 9th, 2024 11:36 am
Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ...
- Apr 9th, 2024 7:02 am
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
- Apr 8th, 2024 8:05 pm
Cue Biopharma to Host Business Update Call and Webcast
- Apr 2nd, 2024 12:00 pm
Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline
- Mar 27th, 2024 2:00 pm
Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
- Feb 29th, 2024 3:00 pm
Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?
- Feb 27th, 2024 9:25 am
Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 6th, 2024 1:00 pm
Cue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years ago
- Jan 17th, 2024 1:09 pm
Are Medical Stocks Lagging Corvus Pharmaceuticals (CRVS) This Year?
- Dec 7th, 2023 2:40 pm
Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit
- Nov 22nd, 2023 1:00 pm
Cue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcript
- Nov 12th, 2023 5:55 pm
Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
- Nov 9th, 2023 9:05 pm
Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November
- Nov 7th, 2023 1:00 pm
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023
- Nov 3rd, 2023 4:00 pm
Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?
- Sep 28th, 2023 9:39 am
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
- Sep 27th, 2023 1:05 pm
Scroll